Diet-dependence of metabolic perturbations mediated by the endocrine disruptor tolylfluanid.

Regnier, Shane M; Kirkley, Andrew G; Ruiz, Daniel; Kamau, Wakanene; Wu, Qian; Kannan, Kurunthachalam; Sargis, Robert M

Regnier, Shane M; Kirkley, Andrew G; Ruiz, Daniel; Kamau, Wakanene; Wu, Qian; Kannan, Kurunthachalam; Sargis, Robert M.

Afiliación

Regnier SM; Committee on Molecular Metabolism and NutritionChicago, Illinois, USA.
Kirkley AG; Pritzker School of MedicineChicago, Illinois, USA.
Ruiz D; University of ChicagoChicago, Illinois, USA.
Kamau W; University of ChicagoChicago, Illinois, USA.
Wu Q; Committee on Molecular Pathogenesis and Molecular MedicineChicago, Illinois, USA.
Kannan K; Committee on Molecular Metabolism and NutritionChicago, Illinois, USA.
Sargis RM; University of ChicagoChicago, Illinois, USA.

Endocr Connect ; 7(1): 159-168, 2018 Jan.

Article en En | MEDLINE | ID: mdl-29187361

Palabras clave

adiposity; diet; endocrine disruptor; glucose tolerance; tolylfluanid

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Endocr Connect Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google